These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19172758)

  • 1. Retraction notice to "Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid for colon-specific drug delivery in inflammatory bowel disease" [European Journal of Medicinal Chemistry 42 (2006) 885-890].
    Dhaneshwar SS; Kandpal M; Vadnerkar G; Rathi B; Kadam SS
    Eur J Med Chem; 2008 Dec; 43(12):2909. PubMed ID: 19172758
    [No Abstract]   [Full Text] [Related]  

  • 2. Retraction notice to "Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid with D-phenylalanine for colon specific drug delivery in inflammatory bowel disease" [Bioorg. Med. Chem. Lett. 17 (2007) 1897-1902].
    Bioorg Med Chem Lett; 2009 Feb; 19(3):1035. PubMed ID: 19434916
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid with D-phenylalanine for colon specific drug delivery in inflammatory bowel disease.
    Dhaneshwar SS; Gairola N; Kandpal M; Bhatt L; Vadnerkar G; Kadam SS
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1897-902. PubMed ID: 17280832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid for colon-specific drug delivery in inflammatory bowel disease.
    Dhaneshwar SS; Kandpal M; Vadnerkar G; Rathi B; Kadam SS
    Eur J Med Chem; 2007 Jun; 42(6):885-90. PubMed ID: 17258353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retraction notice to "Colon-specific, mutual azo prodrug of 5-aminosalicylic acid with L-tryptophan: synthesis, kinetic studies and evaluation of its mitigating effect in trinitrobenzenesulfonic acid-induced colitis in rats" [Bioorg. Med. Chem. 17 (2007) 15 (2007) 4903-4909].
    Dhaneshwar SS; Gairola N; Kandpal M; Vadnerkar G; Bhatt L
    Bioorg Med Chem; 2009 Jan; 17(2):930. PubMed ID: 19177601
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrugs of 5-aminosalicylic acid for colon-specific drug delivery in inflammatory bowel disease.
    Dhaneshwar SS; Gairola N; Kandpal M; Vadnerkar G; Bhatt L; Rathi B; Kadam SS
    Eur J Med Chem; 2009 Oct; 44(10):3922-9. PubMed ID: 19442419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colon-specific, mutual azo prodrug of 5-aminosalicylic acid with L-tryptophan: synthesis, kinetic studies and evaluation of its mitigating effect in trinitrobenzenesulfonic acid-induced colitis in rats.
    Dhaneshwar SS; Gairola N; Kandpal M; Vadnerkar G; Bhatt L
    Bioorg Med Chem; 2007 Jul; 15(14):4903-9. PubMed ID: 17499512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Aminosalicylic Acid Azo-Linked to Procainamide Acts as an Anticolitic Mutual Prodrug via Additive Inhibition of Nuclear Factor kappaB.
    Kim W; Nam J; Lee S; Jeong S; Jung Y
    Mol Pharm; 2016 Jun; 13(6):2126-35. PubMed ID: 27112518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, colon-targeted studies and pharmacological evaluation of an anti-ulcerative colitis drug 4-Aminosalicylic acid-β-O-glucoside.
    Li F; Wu G; Zheng H; Wang L; Zhao Z
    Eur J Med Chem; 2016 Jan; 108():486-494. PubMed ID: 26717200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis.
    Jung Y; Kim HH; Kim H; Kong H; Choi B; Yang Y; Kim Y
    Eur J Pharm Sci; 2006 May; 28(1-2):26-33. PubMed ID: 16455235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and properties of 5-aminosalicyl-taurine as a colon-specific prodrug of 5-aminosalicylic acid.
    Jung YJ; Kim HH; Kong HS; Kim YM
    Arch Pharm Res; 2003 Apr; 26(4):264-9. PubMed ID: 12735682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colon-specific mutual amide prodrugs of 4-aminosalicylic acid for their mitigating effect on experimental colitis in rats.
    Dhaneshwar SS; Chail M; Patil M; Naqvi S; Vadnerkar G
    Eur J Med Chem; 2009 Jan; 44(1):131-42. PubMed ID: 18472188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retraction notice to “2-Azetidinone derivatives: design, synthesis, in vitro anti-microbial, cytotoxic activities and DNA cleavage study”, European Journal of Medicinal Chemistry (2009) 5123-5130.
    Eur J Med Chem; 2011 Jul; 46(7):3177. PubMed ID: 21748868
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and properties of dextran-5-aminosalicylic acid ester as a potential colon-specific prodrug of 5-aminosalicylic acid.
    Jung YJ; Lee JS; Kim HH; Kim YT; Kim YM
    Arch Pharm Res; 1998 Apr; 21(2):179-86. PubMed ID: 9875428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macromolecular prodrug of 4-aminosalicylic acid for targeted delivery to inflamed colon.
    Vadnerkar G; Dhaneshwar S
    Curr Drug Discov Technol; 2013 Mar; 10(1):16-24. PubMed ID: 22725691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vivo Evaluation of 5-ASA Colon-Specific Tablets Using Experimental-Induced Colitis Rat Animal Model.
    Sawarkar SP; Deshpande SG; Bajaj AN; Nikam VS
    AAPS PharmSciTech; 2015 Dec; 16(6):1445-54. PubMed ID: 26017284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colonic delivery of 4-aminosalicylic acid using amylose-ethylcellulose-coated hydroxypropylmethylcellulose capsules.
    Tuleu C; Basit AW; Waddington WA; Ell PJ; Newton JM
    Aliment Pharmacol Ther; 2002 Oct; 16(10):1771-9. PubMed ID: 12269970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biopharmaceutical evaluation of salicylazosulfanilic acid as a novel colon-targeted prodrug of 5-aminosalicylic acid.
    Yamaguchi T; Sasaki K; Kurosaki Y; Nakayama T; Kimura T
    J Drug Target; 1994; 2(2):123-31. PubMed ID: 7915179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of olsalazine.
    Campbell DE; Berglindh T
    Scand J Gastroenterol Suppl; 1988; 148():7-12. PubMed ID: 3067340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of glycine-bearing celecoxib derivatives as a colon-specific mutual prodrug acting on nuclear factor-κB, an anti-inflammatory target.
    Lee S; Lee Y; Kim W; Nam J; Jeong S; Yoo JW; Kim MS; Moon HR; Jung Y
    Drug Des Devel Ther; 2015; 9():4227-37. PubMed ID: 26300626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.